| Aspire Indiana Health Inc. | |
|
2009 Brown St Anderson IN 46016-4216 | |
| (765) 393-3891 | |
| Not Available |
| Full Name | Aspire Indiana Health Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 2009 Brown St, Anderson, Indiana |
| Authorized Official Name and Position | Timothy D Crockett (FINANCIAL OFFICER) |
| Authorized Official Contact | 3175870505 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aspire Indiana Health Inc. 9615 E 148th St Suite 1 Noblesville IN 46060-4360 Ph: (317) 587-0500 | Aspire Indiana Health Inc. 2009 Brown St Anderson IN 46016-4216 Ph: (765) 393-3891 |
| NPI Number | 1780068288 |
|---|---|
| Provider Enumeration Date | 07/14/2015 |
| Last Update Date | 11/03/2023 |
| Medicare PECOS PAC ID | 8921314196 |
|---|---|
| Medicare Enrollment ID | O20150902001749 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780068288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Secondary |
| Provider Name | Bethany Ann Mcgovern |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1922047802 PECOS PAC ID: 2365337862 Enrollment ID: I20040216000177 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Angela Marie Lee |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962452763 PECOS PAC ID: 0840272522 Enrollment ID: I20040605000140 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Joyce M Rand |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1255333126 PECOS PAC ID: 0042294282 Enrollment ID: I20040616000009 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | David J Dwyer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487715074 PECOS PAC ID: 8022083773 Enrollment ID: I20040827000108 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Karen A Iseminger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184696635 PECOS PAC ID: 7719952100 Enrollment ID: I20040830000467 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Michelle Rene Mcdowell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124073242 PECOS PAC ID: 3274508155 Enrollment ID: I20040902000205 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Betsy J Rosiek |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053319095 PECOS PAC ID: 7517927361 Enrollment ID: I20041015000231 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Cynthia K Condry |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1992719413 PECOS PAC ID: 2062310063 Enrollment ID: I20050207000464 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Judi A Knowles |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1346217122 PECOS PAC ID: 0648212365 Enrollment ID: I20050526000760 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Gary P De Sutter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386695658 PECOS PAC ID: 3971545104 Enrollment ID: I20050526000794 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Dale Eugene Sommers |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1659370765 PECOS PAC ID: 3274576079 Enrollment ID: I20050602000759 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Sydney E Ehmke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174517783 PECOS PAC ID: 4183649379 Enrollment ID: I20051006000641 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jeanette Hoeksema |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1023162070 PECOS PAC ID: 7719901115 Enrollment ID: I20060125000137 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Stefane Borders |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1720083835 PECOS PAC ID: 1456360023 Enrollment ID: I20060410000240 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Karen M Lenox |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1598716177 PECOS PAC ID: 5294748547 Enrollment ID: I20060803000204 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Trusa C Grosso |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932242039 PECOS PAC ID: 3173629946 Enrollment ID: I20070511000158 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Michelle Cramer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1447318852 PECOS PAC ID: 2062510753 Enrollment ID: I20070604000420 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Syeda K Khatib |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1982757373 PECOS PAC ID: 8820196942 Enrollment ID: I20070613000112 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Sarah Dross-gonzalez |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1598980468 PECOS PAC ID: 5294820601 Enrollment ID: I20071001000264 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Susan Maier |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881774099 PECOS PAC ID: 4688761653 Enrollment ID: I20071107000730 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Barbara Brands |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053355842 PECOS PAC ID: 8224110903 Enrollment ID: I20080204000214 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Candice J Hunter |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790978245 PECOS PAC ID: 7719053941 Enrollment ID: I20080911000399 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Nelle M Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932277670 PECOS PAC ID: 4486722337 Enrollment ID: I20081006000579 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Chiu-ying Chung |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952406373 PECOS PAC ID: 6608937883 Enrollment ID: I20081205000551 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kathleen I Bowers |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1154562296 PECOS PAC ID: 5092862136 Enrollment ID: I20090407000556 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kristy J Hadfield |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093900193 PECOS PAC ID: 5294884342 Enrollment ID: I20090519000598 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Hua Luo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1659439149 PECOS PAC ID: 2062562283 Enrollment ID: I20090610000297 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Martha A Ponsler |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821156225 PECOS PAC ID: 3971653015 Enrollment ID: I20090610000530 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Elizabeth J Hanrahan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255537106 PECOS PAC ID: 6002968633 Enrollment ID: I20090713000563 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Deena M Heller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841350550 PECOS PAC ID: 3870646557 Enrollment ID: I20090728000426 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Patricia R Fettig |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760633267 PECOS PAC ID: 7416002449 Enrollment ID: I20090827000282 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Linda L Schoneberg |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1619944964 PECOS PAC ID: 9931245271 Enrollment ID: I20090930000232 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Stephanie S Wilson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336479161 PECOS PAC ID: 3476632431 Enrollment ID: I20100618000093 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Emma Ray Engel |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1225235195 PECOS PAC ID: 9931231727 Enrollment ID: I20100714000366 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Mary G Mueller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225115702 PECOS PAC ID: 4688707151 Enrollment ID: I20100804000584 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Debra J Troyer Buck |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1831135607 PECOS PAC ID: 5698890622 Enrollment ID: I20100915000132 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Ginger B Lines |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1912215260 PECOS PAC ID: 5698961878 Enrollment ID: I20101130000952 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Cynthia Branham |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1336442391 PECOS PAC ID: 4385825710 Enrollment ID: I20110218000065 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kelly B Rhoadarmer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1194978981 PECOS PAC ID: 5395929434 Enrollment ID: I20110413000980 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rebecca S Gump |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780798694 PECOS PAC ID: 2668657404 Enrollment ID: I20110421000222 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Patricia D Nikolov |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1154632719 PECOS PAC ID: 9830376797 Enrollment ID: I20110602000473 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Karen L Mcneely |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932101797 PECOS PAC ID: 8628255056 Enrollment ID: I20110610000408 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Thomas Nelson Havill |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093717878 PECOS PAC ID: 3577740893 Enrollment ID: I20110613000881 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Michael Nicholas |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1124026059 PECOS PAC ID: 5698953685 Enrollment ID: I20110622000013 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Brett A Presley |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1255333092 PECOS PAC ID: 8426236878 Enrollment ID: I20110707000205 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Michael E Rose |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659498988 PECOS PAC ID: 6406024041 Enrollment ID: I20110726000254 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jerry Edward Sheward |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1518969369 PECOS PAC ID: 4587832951 Enrollment ID: I20110729000636 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Vanessa Pataky |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326208174 PECOS PAC ID: 1456520956 Enrollment ID: I20110817000427 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Cynthia D Wilson |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1134380124 PECOS PAC ID: 0648442434 Enrollment ID: I20111021000222 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Brad Uebinger |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1174649545 PECOS PAC ID: 6002075041 Enrollment ID: I20120309000481 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jody Horstman |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1477501716 PECOS PAC ID: 4385804764 Enrollment ID: I20120321000751 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Caitlin E Bryte |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972882835 PECOS PAC ID: 8022271634 Enrollment ID: I20120518000004 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Gretchen S Cottrell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962676536 PECOS PAC ID: 6305090135 Enrollment ID: I20130204000087 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Robert J Coykendall |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1356468482 PECOS PAC ID: 0042457657 Enrollment ID: I20130517000480 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Deborah L Shelley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720412380 PECOS PAC ID: 0345478939 Enrollment ID: I20140103000844 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jessica Gardner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1598189946 PECOS PAC ID: 0547490971 Enrollment ID: I20140305001043 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Justin Nelson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1396047007 PECOS PAC ID: 2668603697 Enrollment ID: I20140314001723 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Dianna Huddleston |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821112186 PECOS PAC ID: 8921231200 Enrollment ID: I20140513000663 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Ronda Owens-dehmer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245642024 PECOS PAC ID: 4385860808 Enrollment ID: I20140718000820 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Patricia Jean Manley |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649434663 PECOS PAC ID: 5496977324 Enrollment ID: I20141110001419 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Heather R Stevenson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609294149 PECOS PAC ID: 6800118068 Enrollment ID: I20141126000101 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Joyce Ann Davis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730578436 PECOS PAC ID: 1759608540 Enrollment ID: I20150316000132 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jacqueline Peoples |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831589142 PECOS PAC ID: 6507185584 Enrollment ID: I20150427000275 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Shaun Carrico |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1306105416 PECOS PAC ID: 4587975800 Enrollment ID: I20150612001049 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Martha F Collins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417338591 PECOS PAC ID: 9436461837 Enrollment ID: I20150626000816 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Lindsay Manning |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700268836 PECOS PAC ID: 8224346846 Enrollment ID: I20151001001074 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amy Zinn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750758405 PECOS PAC ID: 7214245570 Enrollment ID: I20151006002336 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Brandy M Lopilato |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952778052 PECOS PAC ID: 1456669514 Enrollment ID: I20151009000948 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Melanie Obremski |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649642414 PECOS PAC ID: 5193034700 Enrollment ID: I20151022000641 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Gina M Marqua |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467827097 PECOS PAC ID: 4688976640 Enrollment ID: I20160107001421 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Marcia Ng |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326411711 PECOS PAC ID: 8123321361 Enrollment ID: I20160122000551 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Robert Beilouny |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1922049626 PECOS PAC ID: 7113223272 Enrollment ID: I20160316000049 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Emily Pierce |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679931661 PECOS PAC ID: 0840395570 Enrollment ID: I20160412000205 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Lindsay M Pringle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104287853 PECOS PAC ID: 6800195199 Enrollment ID: I20160509002385 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Stephanie Sciaudone |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053771535 PECOS PAC ID: 0547553729 Enrollment ID: I20160726001119 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Paul Ludes Braeger |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1205835121 PECOS PAC ID: 3779862834 Enrollment ID: I20161111001222 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | John Meteer |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1619419439 PECOS PAC ID: 8527347624 Enrollment ID: I20161114000240 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Brenda Joseph |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1790793206 PECOS PAC ID: 4284910530 Enrollment ID: I20170420002688 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jillian Condon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023567104 PECOS PAC ID: 6608154927 Enrollment ID: I20170811000732 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Courtney Moore |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801319231 PECOS PAC ID: 2264705029 Enrollment ID: I20170830002751 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rebecca E Lovejoy |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1730596438 PECOS PAC ID: 2062788300 Enrollment ID: I20171101000254 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Julie A Stewart |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609387778 PECOS PAC ID: 8123386513 Enrollment ID: I20171212001768 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Wayne E. Hoye |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306012729 PECOS PAC ID: 2860562626 Enrollment ID: I20171213000775 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jonathan W Butler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386753325 PECOS PAC ID: 3577464395 Enrollment ID: I20171226000133 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Patricia E Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801304423 PECOS PAC ID: 8527328830 Enrollment ID: I20180206002221 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Casimira Lynn Cutrell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376882019 PECOS PAC ID: 7416219209 Enrollment ID: I20180314000950 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Casey Lynn Hill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588153746 PECOS PAC ID: 4587928718 Enrollment ID: I20180515003254 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Olivia H Winn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1699264572 PECOS PAC ID: 2365797206 Enrollment ID: I20180619000314 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amelia Horn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295196673 PECOS PAC ID: 0143510933 Enrollment ID: I20180727002061 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Christine K Dragoo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1255784906 PECOS PAC ID: 2668724758 Enrollment ID: I20181018001318 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Valarie A Anderson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1134694904 PECOS PAC ID: 0749533875 Enrollment ID: I20181018003294 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jaime Bristow |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598250797 PECOS PAC ID: 5698029726 Enrollment ID: I20181108001437 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Katalyn B Richards |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1811465073 PECOS PAC ID: 8729332226 Enrollment ID: I20181120001930 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Christina M Stuckey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841765237 PECOS PAC ID: 3678817996 Enrollment ID: I20181127002714 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Courtney Boswell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730650581 PECOS PAC ID: 9335485556 Enrollment ID: I20190109001782 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Zachari A George |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487126389 PECOS PAC ID: 6709123052 Enrollment ID: I20190124003385 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Melissa Marie Etchison |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518425727 PECOS PAC ID: 5991045734 Enrollment ID: I20190314001028 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Juan R Jaramillo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568579670 PECOS PAC ID: 7315993888 Enrollment ID: I20190319003070 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Joanna Will |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1962961631 PECOS PAC ID: 2062752223 Enrollment ID: I20190326000774 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Lynn M Tolan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1114484920 PECOS PAC ID: 7517208358 Enrollment ID: I20190404002201 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rita Joyce Stephens |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770147704 PECOS PAC ID: 9335482355 Enrollment ID: I20190515000608 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Katherine Nicole Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114588506 PECOS PAC ID: 4981939709 Enrollment ID: I20190716000579 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Katherine Wilson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922650308 PECOS PAC ID: 2365778172 Enrollment ID: I20190731001260 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Desiree Greer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1780101865 PECOS PAC ID: 4284962986 Enrollment ID: I20190819003622 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Patrick E Elzey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346895679 PECOS PAC ID: 0446588891 Enrollment ID: I20190822001463 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Nicholas Rock |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619525383 PECOS PAC ID: 6800125915 Enrollment ID: I20190913001754 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Alyssa Marie Kregloh |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1528512134 PECOS PAC ID: 4981935228 Enrollment ID: I20191017000668 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Huma Hosain |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225477409 PECOS PAC ID: 6103134523 Enrollment ID: I20191023003110 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rana Magill Stoops |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134775463 PECOS PAC ID: 1951734052 Enrollment ID: I20191203003099 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Terry Brewer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477198257 PECOS PAC ID: 4486088531 Enrollment ID: I20191223001645 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Melinda Schadler |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1992341861 PECOS PAC ID: 0749614642 Enrollment ID: I20191231002186 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rebecca M Morris |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659896306 PECOS PAC ID: 2769819234 Enrollment ID: I20200221001328 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Jennifer Wert |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1548882475 PECOS PAC ID: 1052732583 Enrollment ID: I20200609000511 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kelli Siegel |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013529163 PECOS PAC ID: 3779909627 Enrollment ID: I20200821002646 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Ashleigh Wirtner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1942807615 PECOS PAC ID: 2365853652 Enrollment ID: I20201117001468 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Alicia Marie Johnson Bryant |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578924924 PECOS PAC ID: 9931510252 Enrollment ID: I20201117002960 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amanda Slaten |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1245788363 PECOS PAC ID: 3971915851 Enrollment ID: I20201217001739 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Christine Thumma |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437695160 PECOS PAC ID: 6608280334 Enrollment ID: I20210120002911 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Thomas Lims Owusu-asante |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821529371 PECOS PAC ID: 5193139764 Enrollment ID: I20210122002440 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Erika R Bruggeman |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366030611 PECOS PAC ID: 2365856374 Enrollment ID: I20210203001938 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Shannon Moran |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1134663248 PECOS PAC ID: 5698183754 Enrollment ID: I20210409001703 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kimberly Dobbyn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326635392 PECOS PAC ID: 4385052554 Enrollment ID: I20210428001394 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Olivia F Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922504034 PECOS PAC ID: 8729335088 Enrollment ID: I20210719001617 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Melissa Cousins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396821724 PECOS PAC ID: 0840284899 Enrollment ID: I20210802001133 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kaitlyn Dalton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093488843 PECOS PAC ID: 4183028921 Enrollment ID: I20210802001697 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Mary Carr |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871267351 PECOS PAC ID: 6103220058 Enrollment ID: I20210813002557 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amy Doyon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336818186 PECOS PAC ID: 3577960426 Enrollment ID: I20210921000743 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amy M Mitchell |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1114698032 PECOS PAC ID: 3971991167 Enrollment ID: I20211020001335 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amanda Roberts |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891466843 PECOS PAC ID: 8527456524 Enrollment ID: I20211025001363 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kelly Lynn Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518546530 PECOS PAC ID: 5698166676 Enrollment ID: I20211230000584 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Haylee Washington |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1083357818 PECOS PAC ID: 2466849021 Enrollment ID: I20220428001975 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Vivian Hinders |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710623608 PECOS PAC ID: 7618355009 Enrollment ID: I20220525000989 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Olga Marie Dongmo Jiodio |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447995881 PECOS PAC ID: 6709267263 Enrollment ID: I20220715000835 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Herbert Tafadzkia Zinzombe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164178075 PECOS PAC ID: 6709254113 Enrollment ID: I20221116000566 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Janet Ruth Bazzell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1558088187 PECOS PAC ID: 4284007535 Enrollment ID: I20230307001616 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Linda Marie Thomas |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1619395365 PECOS PAC ID: 6103290366 Enrollment ID: I20230330000384 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Shannon Wagoner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760191399 PECOS PAC ID: 4486029451 Enrollment ID: I20230404002084 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Adam Ison |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235827239 PECOS PAC ID: 8527424985 Enrollment ID: I20230510001875 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Tristyn T Ryan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922798925 PECOS PAC ID: 6507227147 Enrollment ID: I20230731001020 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Eboni Starks |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1760160469 PECOS PAC ID: 1355704537 Enrollment ID: I20230906001588 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Elizabeth Coulson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487251930 PECOS PAC ID: 1951721208 Enrollment ID: I20230906002561 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Pei-tzu Angela Su |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144940586 PECOS PAC ID: 1951765163 Enrollment ID: I20230906003154 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Madison Bartlett |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1750063707 PECOS PAC ID: 4789048745 Enrollment ID: I20230911001629 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | James L Lamb |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316655178 PECOS PAC ID: 6800242355 Enrollment ID: I20231019003186 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Shelby Bradford |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1811776099 PECOS PAC ID: 0143676551 Enrollment ID: I20231020002195 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Madison Renee Teskey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710585401 PECOS PAC ID: 1759737174 Enrollment ID: I20231020002371 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Lesley Chodkowski |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1497102255 PECOS PAC ID: 0446608848 Enrollment ID: I20231125000057 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kaitlyn Ervin |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1730549247 PECOS PAC ID: 6103275664 Enrollment ID: I20231208001431 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Ashleigh Smith |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1821776527 PECOS PAC ID: 7315396892 Enrollment ID: I20231208002167 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Amanda L Votaw |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1407308083 PECOS PAC ID: 3072962562 Enrollment ID: I20231208002455 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Brenda Blake |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1487073938 PECOS PAC ID: 2668821166 Enrollment ID: I20231208002685 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Rachael Derrick |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1811421175 PECOS PAC ID: 1355790874 Enrollment ID: I20231209000323 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Katrina Thomas |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639798820 PECOS PAC ID: 1052760576 Enrollment ID: I20231209000437 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Mallory Stapler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518687953 PECOS PAC ID: 7113376641 Enrollment ID: I20231209000573 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Elizabeth Steuer |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1902461544 PECOS PAC ID: 4789033119 Enrollment ID: I20231211003529 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Terri Turner |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1346542016 PECOS PAC ID: 6800245192 Enrollment ID: I20231212002570 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kendall Mosburg |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1003382888 PECOS PAC ID: 9537518683 Enrollment ID: I20231214000722 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Kaitlin Sims |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1861126369 PECOS PAC ID: 2365891470 Enrollment ID: I20231214003433 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Zachary Schenetzke |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1962722959 PECOS PAC ID: 4183846413 Enrollment ID: I20231216000322 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Larry C Davenport |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1396804548 PECOS PAC ID: 4981054723 Enrollment ID: I20231220001763 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
| Provider Name | Isaiah David Thompson |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1700596004 PECOS PAC ID: 5890145148 Enrollment ID: I20231228001682 |
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
News Archive
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
› Verified 3 days ago
Anderson Family Health Specialists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 Medical Arts Blvd, Suite 100, Anderson, IN 46011 Phone: 765-298-5700 Fax: 765-298-4913 | |
Five J Woodall Medical Director Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 299 E 360 N, Anderson, IN 46012 Phone: 765-642-8446 Fax: 765-642-7934 | |
Bridges Campbell & Woodall Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1302 S Madison Ave, Anderson, IN 46016 Phone: 765-644-3673 Fax: 765-644-3680 | |
Craig Groninger Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-1851 Fax: 765-642-3756 | |
United Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 417 W 38th St, Anderson, IN 46013 Phone: 765-400-0380 Fax: 765-400-0381 | |
Caesars Health Center Hoosier Park Anderson Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4500 Dan Patch Cir, Anderson, IN 46013 Phone: 765-609-4711 Fax: 765-609-4713 | |
Indiana Standardbred Association Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3029 E 41st St, Anderson, IN 46013 Phone: 317-621-1230 |